News
- DexCom Inc. gained 0.9% to $84.89 after the provider of monitoring systems for diabetes management reported an 8% revenue growth in the fourth quarter ending in December.
Revenue increased to $1.11 billion from $1.03 billion, net income fell to $151.7 million from $256.3 million, and earnings per diluted share dropped to 38 cents from 62 cents a year ago.
For fiscal 2025, the company estimated revenue of $4.60 billion, up 14% from $4.03 billion a year ago.
Feb 14, 2025 - DexCom declined 3.5% to $72.33 despite the company reporting higher-than-expected quarterly earnings, but slower revenue growth weighed on the stock.
Oct 25, 2024
Links
Price
- Last Close
-
$ 81.03
3.2 %
+2.51
Jan 3, 2025
- Trading Volume
- 94,762
- 52-Week High/Low
- $140 - $68
- Market Cap Full
- $ 26.9B
- YTD
- 4%
Returns +
Q
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 4.2% | 11.8% | 2.6% | -4.9% | -2.7% | -5% | -0.6% | 29.2% | 41.9% | -17.1% | - |
| Q2 | - | -5.1% | 10.6% | -85.5% | 18.6% | 4% | 27.1% | 27.4% | -13.7% | 16.8% | - |
| Q3 | - | 2.3% | -27.4% | 8.1% | 28.7% | 8% | -2.4% | 45.3% | -33.1% | 10.5% | - |
| Q4 | - | 11.4% | 31.2% | 40.6% | -1.7% | -10.3% | 47.5% | -10.4% | 15.6% | -31.9% | - |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 4.2% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -2.2% | -5.2% | 20.6% | -5.8% | - | - | - | 2.3% | - | - | - | 0.1% |
Returns +
A
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | 4% | -37% | 10% | -79% | 46% | 70% | 82% | 109% | -4% | -27% | 49% |
Earnings
| id | company_name | ticker | sector | industry | addresss | state | city | zip | country | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | ||||||||||
| Q2 | ||||||||||
| Q3 | ||||||||||
| Q4 | ||||||||||
| A |